17.—(1) A request for authorisation to conduct a clinical trial shall be made to the licensing authority by the sponsor of the trial.
(2) [F1Subject to paragraph (2A), a] request shall—
(a)be in writing and signed by or on behalf of the sponsor; and
(b)be accompanied by—
(i)the particulars and documents specified in Part 2 of Schedule 3, and
(ii)any fee which may be payable in connection with that application under the Medicines (Products for Human Use—Fees) Regulations 1995 F2.
[F3(2A) No fee need accompany a request where arrangements have been made with the licensing authority for payment of the fee referred to in paragraph (2)(b)(ii) other than at the time of request.]
(3) The request and any accompanying material shall be supplied in the English language.
Textual Amendments
F1Words in reg. 17(2) substituted (29.8.2006) by The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 (S.I. 2006/1928), regs. 1(1), 11(a)